5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) overcomes pharmacological insulin suppression of net hepatic glucose output (NHGO)

被引：0
|
作者：
Camacho, RC
Lacy, DB
James, F
Wasserman, DH
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A372 / A372
页数：1
相关论文
共 50 条
  • [21] Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis
    Paintlia, Ajaib S.
    Paintlia, Manjeet K.
    Singh, Inderjit
    Singh, Avtar K.
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (03): : 1012 - 1025
  • [22] Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1
    Nafz, Julia
    Arce, Johanna De-Castro
    Fleig, Verena
    Patzelt, Andrea
    Mazurek, Sybille
    Roesl, Frank
    BIOCHEMICAL JOURNAL, 2007, 403 (501-510) : 501 - 510
  • [23] Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism
    Tripathi, Versha
    Jaiswal, Pooja
    Assaiya, Anshul
    Kumar, Janesh
    Parmar, Hamendra Singh
    CURRENT CANCER DRUG TARGETS, 2022, 22 (03) : 245 - 256
  • [24] 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase
    Rattan, R
    Giri, S
    Singh, AK
    Singh, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) : 39582 - 39593
  • [25] 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes
    Segalen, Coralie
    Longnus, Sarah L.
    Baetz, Delphine
    Counillon, Laurent
    Van Obberghen, Emmanuel
    ENDOCRINOLOGY, 2008, 149 (04) : 1490 - 1498
  • [26] 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) alters in vitro vasomotor responses of thoracic aorta rings from spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats
    Ford, Rebecca J.
    Rush, James W. E.
    FASEB JOURNAL, 2007, 21 (06): : A1230 - A1230
  • [27] 5-aminoimidazole-4-carboxamide-riboside (AICAR) completely overcomes insulin induced suppression of endogenous glucose production (Ra) during hypoglycemia
    Camacho, RC
    Pencek, RR
    James, FD
    Lacy, DB
    Wasserman, DH
    DIABETES, 2004, 53 : A372 - A373
  • [28] Portal venous 5-aminoimidazole4-carboxamide-1-beta-4-ribofuranoside (AICAR) infusion causes acute hepatic insulin resistance in vivo
    Pencek, RR
    Shearer, J
    Camacho, RC
    James, FD
    Lacy, DB
    Fueger, PT
    Wasserman, DH
    DIABETES, 2004, 53 : A364 - A364
  • [29] Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner
    Buhl, ES
    Jessen, N
    Schmitz, O
    Pedersen, SB
    Pedersen, O
    Holman, GD
    Lund, S
    DIABETES, 2001, 50 (01) : 12 - 17
  • [30] Activation of AMP-Activated Protein Kinase by 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in the Muscle Microcirculation Increases Nitric Oxide Synthesis and Microvascular Perfusion
    Bradley, Eloise A.
    Eringa, Etto C.
    Stehouwer, Coen D. A.
    Korstjens, Iolente
    Amerongen, Geerten P. van Nieuw
    Musters, Rene
    Sipkema, Pieter
    Clark, Michael G.
    Rattigan, Stephen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (06) : 1137 - 1142
12345